Van Hulzen Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-319
| Closed | -$128K | – | 1095 |
|
|
2024
Q4 | $128K | Buy |
+319
| New | +$128K | 0.01% | 363 |
|
|
2023
Q2 | – | Sell |
-5,163
| Closed | -$1.63M | – | 336 |
|
|
2023
Q1 | $1.63M | Sell |
5,163
-547
| -10% | -$172K | 0.15% | 95 |
|
|
2022
Q4 | $1.65M | Sell |
5,710
-4
| -0.1% | -$1.16K | 0.19% | 99 |
|
|
2022
Q3 | $1.65M | Buy |
5,714
+14
| +0.2% | +$4.05K | 0.2% | 94 |
|
|
2022
Q2 | $1.61M | Sell |
5,700
-71,600
| -93% | -$20.2M | 0.19% | 91 |
|
|
2022
Q1 | $20.2M | Buy |
77,300
+7,399
| +11% | +$1.93M | 2.14% | 9 |
|
|
2021
Q4 | $15.4M | Buy |
+69,901
| New | +$15.4M | 1.68% | 15 |
|